|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02160 CARDIOFLOW-B
Nominal 
0.670 0.000 (0.000%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 336,215 | 33.936% | 251,026 | 200,813 | 103,934 | 21,502 |
| Cost of Sales | (106,284) | 19.560% | (88,896) | (82,112) | (58,554) | (15,200) |
| Gross Profit | 229,931 | 41.819% | 162,130 | 118,701 | 45,380 | 6,302 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (131,508) | 55.249% | (84,708) | 23,419 | (64,743) | (8,649) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (64,457) | -7.001% | (69,309) | (3,512) | 716 | 0 | |
| Profit / (Loss) before Taxation | (463,582) | 2.722% | (451,299) | (182,651) | (398,087) | (144,522) | |
| Taxation | (7,952) | 156.848% | (3,096) | (613) | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (471,534) | 3.772% | (454,395) | (183,264) | (398,087) | (144,522) | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (82,397) | 147.952% | (33,231) | (4,810) | 141,083 | 12,463 |
| Depreciation & Amortisation | 73,618 | -5.877% | 78,215 | 44,423 | 24,503 | 13,760 |
| Directors' Emoluments | 14,124 | 51.936% | 9,296 | 10,527 | 18,267 | 4,346 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -20.000 | 5.263% | -19.000 | -8.000 | -23.000 | -8.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.088) | -- | (0.077) | (0.069) | (0.064) | (0.082) |
| NBV per share ($) | 0.968 | -- | 1.143 | 1.288 | -- | -- |
| Remarks: | Real time quote last updated: 23/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -56,461,000 |
| %Change | -68.528% |
| EPS / (LPS) | RMB -0.020 |
| NBV Per Share (¥) | RMB 0.896 |